tiprankstipranks
Trending News
More News >
Pasithea Therapeutics 3.57M share Secondary priced at $1.40
PremiumThe FlyPasithea Therapeutics 3.57M share Secondary priced at $1.40
1M ago
Pasithea Therapeutics announces interim data from Phase 1 trial of PAS-004
Premium
The Fly
Pasithea Therapeutics announces interim data from Phase 1 trial of PAS-004
1M ago
Pasithea Therapeutics files to sell 3.25M shares of common stock, warrants
Premium
The Fly
Pasithea Therapeutics files to sell 3.25M shares of common stock, warrants
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
Pasithea announces Safety Review Committee recommendation
Premium
The Fly
Pasithea announces Safety Review Committee recommendation
4M ago
Pasithea Therapeutics opens three clinical trial sites in Eastern Europe
Premium
The Fly
Pasithea Therapeutics opens three clinical trial sites in Eastern Europe
5M ago
Pasithea Therapeutics announces initial data from Phase 1 trial of PAS-004
PremiumThe FlyPasithea Therapeutics announces initial data from Phase 1 trial of PAS-004
8M ago
Pasithea Therapeutics completes PAS-004 chronic toxicity studies
Premium
The Fly
Pasithea Therapeutics completes PAS-004 chronic toxicity studies
9M ago
Pasithea Therapeutics appoints Rebecca Brown to Scientific Advisory Board
Premium
The Fly
Pasithea Therapeutics appoints Rebecca Brown to Scientific Advisory Board
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100